BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jeulin H, Velay A, Murray J, Schvoerer E. Clinical impact of hepatitis B and C virus envelope glycoproteins. World J Gastroenterol 2013; 19(5): 654-664 [PMID: 23429668 DOI: 10.3748/wjg.v19.i5.654]
URL: https://www.wjgnet.com/1007-9327/full/v19/i5/654.htm
Number Citing Articles
1
Riki Toita, Takahito Kawano, Jeong-Hun Kang, Masaharu Murata. Applications of human hepatitis B virus preS domain in bio- and nanotechnologyWorld Journal of Gastroenterology 2015; 21(24): 7400-7411 doi: 10.3748/wjg.v21.i24.7400
2
Carmen Mirabelli, Matteo Surdo, Formijn Van Hemert, Zhichao Lian, Romina Salpini, Valeria Cento, Maria Francesca Cortese, Marianna Aragri, Michela Pollicita, Claudia Alteri, Ada Bertoli, Ben Berkhout, Valeria Micheli, Guido Gubertini, Maria Mercedes Santoro, Sara Romano, Michela Visca, Martina Bernassola, Roberta Longo, Giuseppe Maria De Sanctis, Pascal Trimoulet, Hervè Fleury, Nicoletta Marino, Francesco Mazzotta, Giuseppina Cappiello, Alberto Spanò, Cesare Sarrecchia, Jing Maria Zhang, Massimo Andreoni, Mario Angelico, Jens Verheyen, Carlo Federico Perno, Valentina Svicher. Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionJournal of Infection 2015; 70(3): 288 doi: 10.1016/j.jinf.2014.10.015
3
Kyoko TSUKIYAMA-KOHARA, Michinori KOHARA. <i>Tupaia Belangeri</i> as an Experimental Animal Model for Viral InfectionExperimental Animals 2014; 63(4): 367 doi: 10.1538/expanim.14-0007
4
Ding Shen, Jie Zheng, Xiping Cui, Yingshan Chen, Qiyi He, Rui Lv, Zhaoxia Li, Suqing Zhao. Analysis of cholyglycine acid as a biomarker for the early diagnosis of liver disease by fluorescence polarization immunoassaySensors and Actuators B: Chemical 2018; 256: 846 doi: 10.1016/j.snb.2017.10.013
5
Shuji Hinuma, Kazuyo Fujita, Shun’ichi Kuroda. Binding of Nanoparticles Harboring Recombinant Large Surface Protein of Hepatitis B Virus to Scavenger Receptor Class B Type 1Viruses 2021; 13(7): 1334 doi: 10.3390/v13071334
6
Graziella El Khoury, Basmah Khogeer, Chen Chen, Kheng T Ng, Shaleem I Jacob, Christopher R Lowe. Bespoke affinity ligands for the purification of therapeutic proteinsPharmaceutical Bioprocessing 2015; 3(2): 139 doi: 10.4155/pbp.14.60
7
Kouka Saadeldin Abdelwahab, Zeinab Nabil Ahmed Said. Status of hepatitis C virus vaccination: Recent updateWorld Journal of Gastroenterology 2016; 22(2): 862-873 doi: 10.3748/wjg.v22.i2.862
8
Shuji Hinuma, Shun’ichi Kuroda. Binding of Hepatitis B Virus Pre-S1 Domain-Derived Synthetic Myristoylated Peptide to Scavenger Receptor Class B Type 1 with Differential Properties from Sodium Taurocholate Cotransporting PolypeptideViruses 2022; 14(1): 105 doi: 10.3390/v14010105
9
Xuan Guo, Jin-Yi Zhong, Jun-Wen Li. Hepatitis C Virus Infection and Vaccine DevelopmentJournal of Clinical and Experimental Hepatology 2018; 8(2): 195 doi: 10.1016/j.jceh.2018.02.003
10
Xiaoyu Chu, Bo Wu, Hongxia Fan, Junwei Hou, Junli Hao, Jun Hu, Baozhong Wang, Guangze Liu, Changfei Li, Songdong Meng. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expressionAntiviral Research 2016; 127: 41 doi: 10.1016/j.antiviral.2016.01.008
11
Albert Ndzengue, Lewis R. Roberts. Viruses and Human Cancer2014; : 51 doi: 10.1007/978-1-4939-0870-7_4
12
Kyoko TSUKIYAMA-KOHARA, Michinori KOHARA. <i>Tupaia Belangeri</i> as an Experimental Animal Model for Viral InfectionExperimental Animals 2014; 63(4): 367 doi: 10.1538/expanim.63.367
13
Carmen L. Delgado, Elena Núñez, Belén Yélamos, Julián Gómez-Gutiérrez, Darrell L. Peterson, Francisco Gavilanes. Study of the putative fusion regions of the preS domain of hepatitis B virusBiochimica et Biophysica Acta (BBA) - Biomembranes 2015; 1848(4): 895 doi: 10.1016/j.bbamem.2014.12.020